Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Women's Studies |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/15/2018 |
| Start Date: | September 1, 2018 |
| End Date: | August 30, 2020 |
Immediate Postpartum LARC Implementation: Pilot Study at Michigan Medicine
The objective of this study is to test and disseminate tools that drive successful immediate
postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is
to reduce unintended pregnancy soon after childbirth by increasing access to immediate
postpartum LARC for women who desire it.
postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is
to reduce unintended pregnancy soon after childbirth by increasing access to immediate
postpartum LARC for women who desire it.
Based on previous work, the investigators have generated a toolkit to guide the integration
of immediate postpartum LARC services into widespread clinical practice. In the proposed
work, this toolkit will be used to initiate immediate postpartum LARC services in a single
site with low baseline immediate postpartum LARC uptake (Michigan Medicine). The
investigators will conduct a feasibility study using mixed methods to assess acceptability
and appropriateness of toolkit items; patient experience of care; immediate postpartum LARC
utilization rate; and prenatal contraceptive counseling rate.
of immediate postpartum LARC services into widespread clinical practice. In the proposed
work, this toolkit will be used to initiate immediate postpartum LARC services in a single
site with low baseline immediate postpartum LARC uptake (Michigan Medicine). The
investigators will conduct a feasibility study using mixed methods to assess acceptability
and appropriateness of toolkit items; patient experience of care; immediate postpartum LARC
utilization rate; and prenatal contraceptive counseling rate.
Inclusion Criteria:
- Female (patients)
- Pregnant (patients)
- Receiving obstetrical care at Michigan Medicine (patients)
- L&D provider at Michigan Medicine (providers)
Exclusion Criteria:
- non-English speaking
- unable to provide informed consent
We found this trial at
1
site
Click here to add this to my saved trials
